Showing results (561-570 of 603) with videos related to

Sort By:
Pageof 61
EFSA Journal. European Food Safety Authority|December 13, 2021
Assessment of the control measures of the category A diseases of Animal Health Law: Newcastle disease, Søren Saxmose Nielsen, Julio Alvarez, et al.
EFSA Journal. European Food Safety Authority|November 1, 2023
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) 2016/429): Spring Viraemia of Carp (SVC), Søren Saxmose Nielsen, Julio Alvarez, et al.
EFSA Journal. European Food Safety Authority|November 1, 2023
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU)2016/429): Infection with salmonid alphavirus (SAV), Søren Saxmose Nielsen, Julio Alvarez, et al.
EFSA Journal. European Food Safety Authority|February 8, 2021
Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: African Swine Fever, Søren Saxmose Nielsen, Julio Alvarez, et al.
EFSA Journal. European Food Safety Authority|October 6, 2020
Rift Valley Fever - epidemiological update and risk of introduction into EuropeSøren Saxmose Nielsen, Julio Alvarez, Dominique Joseph Bicout, et al.
EFSA Journal. European Food Safety Authority|February 8, 2021
Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: African Horse Sickness, Søren Saxmose Nielsen, Julio Alvarez, et al.
EFSA Journal. European Food Safety Authority|July 26, 2021
Assessment of the control measures of the category A diseases of Animal Health Law: Classical Swine Fever, Søren Saxmose Nielsen, Julio Alvarez, et al.
EFSA Journal. European Food Safety Authority|January 25, 2021
Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: Highly Pathogenic Avian Influenza, Søren Saxmose Nielsen, Julio Alvarez, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2025
Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancerChristopher W Schultz, Sourav Saha, Anjali Dhall, et al.
The Lancet. Oncology|August 12, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trialPierre Vera, Sébastien Thureau, Florence Le Tinier, et al.
Pageof 61